II
KURA icon

Ishara Investments’s Kura Oncology KURA Stock Holding History

Ishara Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
+276,750
New +$2.61M 2.23% 18

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Ishara Investments's KURA Position: Q2 2026 in Review

Ishara Investments opened a new position in Kura Oncology (KURA) in Q2 2026: 276,750 shares worth $3.04M. The stake represents 2.23% of the portfolio and ranks #18 among its holdings.

220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Ishara Investments held 276,750 shares of Kura Oncology worth $3.04M as of Q2 2026.
  • Kura Oncology was a new Ishara Investments position in Q2 2026.
  • Kura Oncology made up 2.23% of Ishara Investments's portfolio in Q2 2026, its #18 holding.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.